HHS Secretary Nominee Becerra Plans ‘Swift’ Action On Drug Pricing Reform
Executive Summary
‘We need the pharmaceutical industry … to always feel we’ve got their back to innovate,’ Becerra tells Senate Committee. ‘But we have to ensure that we’re getting our dollars’ worth.’
You may also be interested in...
AAM Succeeds As California Court Temporarily Blocks Pay-For-Delay Law
A judge in California has agreed to instate a temporary injunction against a state law designed to curb so-called ‘pay-for-delay’ deals, handing victory to generics and biosimilars industry association the AAM.
Becerra Takes The Helm At HHS; More Visibility On Administration’s Drug Pricing Priorities To Follow
Becerra’s HHS has a new crop of former Capitol Hill staffers in its policy ranks who are well versed on legislation in the health care realm, including prescription drug pricing reform. That will help advance the Administration’s agenda.
US FDA Commissioner Race Shrinks And Widens: Biden Team Trying To Woo Reluctant Dems On Woodcock While Exploring New Options
White House is trying to overcome some Senate Democrats’ opposition to Janet Woodcock as FDA Commissioner, while also looking for other candidates for the job. Josh Sharfstein, long thought to be Woodcock’s main competition, is not a strong contender.